November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Blood Cancers Today – Is reduced-duration venetoclax in AML effective?
Jun 21, 2024, 07:47

Blood Cancers Today – Is reduced-duration venetoclax in AML effective?

Blood Cancers Today shared a post on X:

Is reduced-duration venetoclax in AML effective?
 A study presented at EHA2024 by Christophe Willekens, MD, of Gustave Roussy, compares reduced venetoclax exposure of seven days with standard continual venetoclax exposure.

Blood Cancers Today

Read further.
Source: Blood Cancers Today/X